Industry Overview of Cytokine Market
Cytokines are small proteins paramount in cell signaling and communication and help regulate immune responses and inflammation. They are produced by a wide array of cells, which include macrophages, B lymphocytes, T lymphocytes, mast cells, endothelial cells, and fibroblasts. They exhibit a high level of pleiotropy and redundancy, meaning that their actions can overlap, and multiple cytokines can elicit similar responses. They aid in promoting cell growth and differentiation and coordinating the cellular response to various stimuli, such as infection and injury. Besides this, as they offer potential targets for the development of treatments for various diseases, the demand for cytokines is increasing globally.
How Big Is The Cytokine Market?
The global cytokine market size reached US$ 83.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 130.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.66% during 2023-2028.
What Are The Growth Prospects And Trends In The Cytokine Industry?
The rising prevalence of several chronic diseases is leading to an increasing demand for effective treatments and therapies. Additionally, the increasing use of cytokines in the pharmaceutical industry, on account of their immune responses and inflammation, is favoring market growth. Apart from this, the technological advancement in bio-production and purification methods, coupled with the development of more efficient and cost-effective processes for cytokine production, is continually enhancing the accessibility and affordability of cytokine-based therapies. Furthermore, the growing focus on research and development (R&D) in biotechnology and pharmaceuticals is offering a favorable market outlook. Moreover, government policies promoting biomedical research, along with funding support for innovative projects, are driving forward the development and application of cytokines in various therapeutic areas.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Cytokine Type:
- Tumor Necrosis Factor-TNF
- Interleukins-Il
- Interferons-IFN
- Epidermal Growth Factor-EGF
- Others
Breakup by Therapeutic Application:
- Cancer
- Asthma and Airway Inflammation
- Arthritis
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.
